1
|
Yıldırım A, Öztürk Haney M. Asthma self-efficacy scale for teachers: psychometric properties of the Turkish version. J Asthma 2023; 60:2207-2213. [PMID: 37354092 DOI: 10.1080/02770903.2023.2228910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 06/08/2023] [Accepted: 06/20/2023] [Indexed: 06/26/2023]
Abstract
OBJECTIVE Asthma is common among Turkish schoolchildren, and teachers thus have considerable responsibility for asthma management in schools. However, there is no valid and reliable instrument to evaluate teachers' asthma management self-efficacy in schools. The purpose of this study was to investigate the cross-cultural adaptation and psychometric properties of the Turkish version of the Asthma Self-Efficacy Scale (ASE-T) among elementary school teachers. METHODS This methodological study included 216 elementary school teachers. The reliability of the ASE-T was expressed using Cronbach's alpha coefficient and item-total score correlations. The validity of the scale was examined via confirmatory factor analysis, item analysis, and the content validity index. RESULTS The Cronbach's alpha coefficient of the scale was 0.70, and the item-total score correlations ranged between 0.24 and 0.57. The results of the confirmatory factor analysis determined the model fit indices to be χ2/df = 1.461, RMSEA = 0.046, GFI = 0.94, AGFI = 0.91, NNFI = 0.98, and CFI = 0.92. The item analysis results revealed the differences between teachers with low and high levels of self-efficacy. CONCLUSION The results indicated the usefulness of the ASE-T for Turkish teachers. It is essential to determine teachers' competence in asthma management in order to improve their performance in school settings.
Collapse
Affiliation(s)
- Atiye Yıldırım
- Institute of Health Science, Dokuz Eylul University, Izmir, Turkey
| | | |
Collapse
|
2
|
Zeitouni MO, Al-Moamary MS, Coussa ML, Riachy M, Mahboub B, AlHuraish F, Zidan MH, Metwally MM, Aksu K, Yavuz E, Kalla IS, Chakaya J, Abdelmadjid S, Ghedira H. Challenges and recommendations for the management of asthma in the Middle East and Africa. Ann Thorac Med 2022; 17:71-80. [PMID: 35651897 PMCID: PMC9150662 DOI: 10.4103/atm.atm_469_21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 01/18/2022] [Indexed: 11/04/2022] Open
Abstract
Clinical presentation of asthma is variable, and its diagnosis can be a major challenge in routine health-care practice, especially in low-and-middle-income countries. The aim of asthma management is to achieve optimal asthma control and to reduce the risk of asthma exacerbations and mortality. In the Middle East and in Africa (MEA), several patient- and physician-related factors lead to misdiagnosis and suboptimal management of asthma. A panel of experts comprising of specialists as well as general health-care professionals met to identify challenges and provide recommendations for the management of asthma in MEA. The major challenges identified for diagnosis of asthma were lack of adequate knowledge about the disease, lack of specialized diagnostic facilities, limited access to spirometry, and social stigma associated with asthma. The prime challenges for management of asthma in MEA were identified as overreliance on short-acting β-agonists (SABAs), underprescription of inhaled corticosteroids (ICS), nonadherence to prescribed medications, and inadequate insurance coverage for its treatment. The experts endorsed adapting the Global Initiative for Asthma guidelines at country and regional levels for effective management of asthma and to alleviate the overuse of SABAs as reliever medications. Stringent control over SABA use, discouraging over-the-counter availability of SABA, and using as-needed low-dose ICS and formoterol as rescue medications in mild cases were suggested to reduce the overreliance on SABAs. Encouraging SABA alone-free clinical practice in both outpatient and emergency department settings is also imperative. We present the recommendations for the management of asthma along with proposed regional adaptations of international guidelines for MEA.
Collapse
Affiliation(s)
- Mohamed Omar Zeitouni
- Pulmonary Medicine and Critical Care, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | - Mohamed Saad Al-Moamary
- Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Marie Louise Coussa
- Division of Pulmonary Diseases, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon
| | - Moussa Riachy
- Department of Pulmonary and Critical Care Medicine, Hotel Dieu De France Hospital, Beirut, Lebanon
| | - Bassam Mahboub
- Department of Pulmonary Medicine, Rashid Hospital, Dubai Academic City, United Arab Emirates
| | - Fatma AlHuraish
- Respiratory Unit, Department of Internal Medicine, Al Sabah Hospital, Ministry of Health, Kuwait
| | - Mohamed Helmy Zidan
- Department of Chest Diseases, Faculty of Medicine, Alexandria University, Egypt
| | | | - Kurtuluş Aksu
- Clinic of Chest Diseases, Immunology and Allergic Diseases, Ankara Atatürk Chest Diseases and Chest Surgery Hospital, Ankara, Turkey
| | - Erdinç Yavuz
- Department of Family Medicine, Samsun University, Samsun, Turkey
| | - Ismail Sikander Kalla
- Pulmonologist, Suite D2 Ahmed Kathrada Private Hospital, K43 Highway, Lenasisa Ext 8, 1827, South Africa
| | - Jeremiah Chakaya
- Physician, Fourth Floor Room 404 Fortis Suites, Hospital Road, 00100, Nairobi, Kenya
| | - Snouber Abdelmadjid
- Chest Clinic, Faculty of Medicine, CHU ORAN University of Oran, Oran, Algeria
| | - Habib Ghedira
- Department of Pathology, CHU Abderrahmen Mami, Ariana, Tunisia
| |
Collapse
|
3
|
ATEŞ H, AKSU K, ÖZDEDEOĞLU Ö, BAŞA AKDOĞAN B, KOCA KALKAN İ, KÖYCÜ G, ONER F. Direct cost analysis for patients with severe asthma receiving omalizumab treatment. JOURNAL OF HEALTH SCIENCES AND MEDICINE 2021. [DOI: 10.32322/jhsm.959689] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|